Mentor Capital, Inc (MNTR) Chairman and CEO, Chet Billingsley, Discusses Exciting Company Growth

Mentor Capital, Inc. Chairman and CEO, Chet Billingsley, Discusses Exciting Company Growth with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

Mentor Capital, Inc., just uplisted recently with their ticker symbol now at OTCQX:MNTR.

Everett Jolly indicated that today’s guest hasn’t been on the show for a couple of years, but that he’s super excited to have them back. He introduced Mentor Capital, Inc. Chairman and CEO, Chet Billingsley, who after West Point received his Master’s degree at Harvard, with an investment background after his years at General Electric. So, he’s now focusing his energies in the cannabis sector, which will make for an interesting interview. “Chet, welcome to the show! What exactly does Mentor do? Draw us out a road map of who you are and where you’re going.”

For 32 years, the Company has been providing advice and financing for companies, starting in Silicon Valley, then to San Diego into the biotech sector in particular for cancer. Then the Company shifted to a cancer-focused medical marijuana investment, which brought them into the cannabis sector. They are currently looking at the larger cannabis companies who have the potential to go public and Mentor Capital helps them set up their financial and legal structure. During this process, they then get funding and act much as a public company under Mentor’s umbrella, providing liquidity along with the ability to make some strategic decisions. When those companies are ready, they can spin-off as stand-alone public companies with Mentor’s 13,000 investors who might be particularly interested in the cannabis sector.

Jolly commented that the Company just filed its 10-Q during the Second Quarter and asked the CEO for more information. Billingsley responded that it was a 60% year-over-year growth in revenue. Also, moving up to the OTCQX arena has special significance with the SEC. It now makes it easier for the Company to talk with some of the larger brokerages that normally can’t talk to anyone, say, in the normal Pink Sheets.

“Chet, you’ve been in the cannabis industry now since 2013. What changes do you see coming and what changes have you already seen?”

Continue reading
  5 Hits
  0 Comments
5 Hits
0 Comments

Marijuana Stocks Newsletter – Happy Monday August 20, 2018

Other Industries Seeing Benefit From MJ! Cannabis has opened some big doors and early opportunity but do you know how it has impacted other indusrties? One sector has presented immense potential for capitalizing on the medical side of this budding market and one company may be on the verge of a major breakthrough!Click Here For More Details

Canada’s Green Rush Is Coming; Time To Get ReadyA financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company has put its wheels in motion & that could mean big potential aheadClick Here For More Information

Top Cannabis Biotech Stocks to WatchThe cannabis market has been growing with a massive amount of propensity toward the future for some time now. With new laws going into place around the world and a changing public perception on the plant as a whole, it seems as though now is a better time than ever to watch the cannabis space. Biotech stocks within the cannabis market have also been growing with a massive amount of energy into the future as new laws continue to favor cannabis as a choice over traditional drugs for everything from pain to nausea treatments. More Details Here

Disclaimer: An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by GT Biopharma Inc. for a period beginning July 16, 2018 and ending August 16, 2018 to publicly disseminate information about (GTBP). We own zero shares. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018 NOW EXTENDED TO 8/31/2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

The post Marijuana Stocks Newsletter – Happy Monday August 20, 2018 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
  4 Hits
  0 Comments
4 Hits
0 Comments

Top Cannabis Biotech Stocks to Watch Out For

The cannabis market has been growing with a massive amount of propensity toward the future for some time now. With new laws going into place around the world and a changing public perception on the plant as a whole, it seems as though now is a better time than ever to watch the cannabis space. Biotech stocks within the cannabis market have also been growing with a massive amount of energy into the future as new laws continue to favor cannabis as a choice over traditional drugs for everything from pain to nausea treatments.

One of the main stocks in the industry has been GW Pharmaceuticals (NASDAQ:GWPH) The company currently has a market cap of around $150 million which means that they are on the larger side of the industry, but still relatively in the middle when compared to other stocks in the space. The company has stated that their sales are expected to jump from around $20 million to over $150 million during the course of the next year. One research report states that this massive growth has mainly come from “the approval of cannabidiol-based drug Epidiolex on June 25 by the U.S. Food and Drug Administration (FDA). This therapy, which is the first cannabis-derived drug to get the green light from the FDA, is designed to treat two rare types of childhood-onset epilepsy known as Dravet syndrome and Lennox-Gastaut syndrome. Since there were no other FDA-approved treatments for Dravet syndrome prior to this approval, GW Pharmaceuticals looks to have a clear path to success.” The FDA’s approval of this drug also signaled a very large change in the industry as a whole as this was the first time that the governing body so unanimously decided to approve a cannabis-based drug. All in all, GW should remain on any investors watch list.

The next stock on the list is the company GT Biopharma (OTC:GTBP). According to one report, the company “GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of novel immuno-oncology products based off its proprietary technology platforms. The company develops immuno-oncology product candidates.” These medicines have become extremely popular as more and more realize the massive amount of potential when using cannabis to treat a wide variety of illnesses. The company has a market cap of around $100 million which also puts them in the medium-sized company space for the whole of the cannabis market. All in all, GT Biopharma remains an incredibly interesting stock to watch over the course of the next few years.

The last stock on the list and one that should be a household name in the industry by now is the company Cara Therapeutics (CARA). With a market cap of around $730 million, the company is on the higher side of the companies in the cannabis space. As a purely biopharmaceutical business, Cara Therapeutics is stated to be a “ company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, announced that it has licensed worldwide rights, except in the U.S., Japan and South Korea, to commercialize KORSUVA (CR845/difelikefalin) injection for the treatment of chronic kidney disease-associated pruritus.” The company has continued to make revolutionary drugs using the cannabis plant, and continues to be a favorite among investors.

The hopes are high that the industry on cannabis can continue to fuel investments into the biotech sector as the massive amount of potential will hopefully drive even more growth in the near future.

Continue reading
  4 Hits
  0 Comments
4 Hits
0 Comments

Aurora Cannabis Inc. (ACBFF) Sets Record Date of Australis Capital Distribution

Aurora Cannabis Sets Record Date of Australis Capital Distribution

Aurora Cannabis Inc. (“Aurora” or the “Company”) (ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) today announced that, in connection with the spin-out of its subsidiary Australis Capital Inc. (“Australis”), Aurora has set Friday August 24, 2018 as the record date for the distribution of Australis units (the “Distribution”).

Canadian shareholders as at the record date will be eligible to receive the Distribution. Non-resident shareholders will be entitled to receive a cash payment net of any applicable withholding taxes following a sale of their respective units in the open market by an independent custodian following the Distribution. Consequently, Aurora anticipates the completion of the Distribution to shareholders and the public listing of Australis on the CSE to be completed in September 2018 .

As previously announced on August 17, 2018 , the Distribution will be paid on the basis of one unit for every 34 Aurora shares outstanding on the record date. Each unit will consist of one common share and one share purchase warrant of Australis. Each warrant will entitle the holder thereof to acquire one share at an exercise price of $0.25 per Australis share, on or prior to 4:00 p.m. (Eastern Time) on the date that is one year after the Distribution.

In accordance with applicable securities laws, only Canadian beneficial shareholders can participate in the Distribution. Canadian beneficial shareholders or their broker representatives are required to confirm Canadian residency by no later than September 14, 2018 , otherwise they will be deemed to be non-resident shareholders and will receive the net cash proceeds from the sale of their units.  Canadian shareholders who hold their shares in Aurora through a brokerage or other account are therefore urged to contact their brokers to ensure that their brokers have confirmed Canadian residency in the manner to be provided by CDS following the record date.

Management Commentary

Continue reading
  5 Hits
  0 Comments
5 Hits
0 Comments

mCig, Inc. (MCIG) Announces First Hemp Harvest With NYAcres to Begin Soon

MCIG Announces First Hemp Harvest With NYAcres to Begin Soon

mCig, Inc. (MCIG), a diversified company servicing the legal cannabis markets, announced today that it will begin harvesting its first crop of organic hemp from NYAcres in two to three weeks time.

To oversee the harvest and curing process, MCIG brought on Chadd McKeen , co-author of Idiots Guide: Growing Marijuana and founding partner at Canna Mana Trading Company. With over 12 years of experience in cannabis cultivation, Mr. McKeen will be onsite to jump-start the post-grow process, from the actual mechanics of the harvest to extraction and buyer relationships.

The NYAcres project began in June 2018 as a joint project with FarmOn!Foundation. The 55,000 pound yield of hemp bio-mass will be a huge growth generator for MCIG, its recently launched CBD Market (www.cbd.biz), and new CBD pet line, Artax (www.cbd.biz/portfolio/artax/).

After harvested and dried, cannabidiol (CBD) will be extracted from the plant source material. The particular strains of hemp grown at NYAcres, Cherry Wine and Berry Blue sourced from the Colorado Hemp Project are known for their high concentrations of CBD. Once extracted, CBD distillate can be used as a component for a diverse range of end user products, from CBD capsules to CBD vape. Initial projections from our Advisory team and based upon their collective years of farm production and development; we expect revenues greater than $10 million annually from the 40-acre yield. With 212 total acres available, the NYAcres Project could potentially yield up to $50 million per year in high demand CBD retail products with this unique approach.

“MCIG will continue to seek strategic partnerships in hemp agriculture,” says Paul Rosenberg, MCIG CEO. “The success of this venture with NYAcres is just the beginning. As the public demand for CBD and other hemp products grows, so does the need for a consistent hemp supply. With true hemp legalization on the horizon in the US, MCIG is well-positioned to capitalize on the growth of this soon-to-be billion dollar industry.”

Continue reading
  4 Hits
  0 Comments
4 Hits
0 Comments

Investors Continue to Favor Cannabis Stocks as Market Grows

As legalization continues to occur for cannabis around the world, more and more investors are excited about investing in the marijuana space. Many stocks have recently seen increases in their value as people become comfortable with cannabis as an investment and as laws continue to change. With some estimates showing that the cannabis space could in Canada alone, reach $5 billion in annual sales, it seems as though there is a lot of potential in the cannabis market as a whole.

The main stock that people have been talking about in the industry has been Canopy Growth Corp (NYSE:CGC) Canopy recently signed into a deal with Constellation Brands (NYSE:STZ) adding around $4 billion in investments to the former. The company currently has almost 6 million square feet of growing capacity, which means that they are perfectly poised to grow from the new recreational cannabis laws going into place in Canada. According to one report, in addition “Health Canada has already given the green light to 2.4 million square feet of production space, which should give the company more than ample capacity to nab significant recreational market share when the green flag waves in two months’ time.”

Canopy has also remained one of the most recognizable brands throughout Canada which means that they should have a large amount of potential to continue this growth trend into the near future, but only time will tell.

The company Aphria (NASDAQOTH:APHQF) is another one of the big players in the Canadian cannabis industry. The company has stated that they are going to see as much as $356 million in sales during the fiscal year of 2019. This large amount of revenue is subject to come from a series of various projects. The first project is known as Aphria One, which as the company states is “the company’s flagship organic build-out. This four-phase expansion is costing Aphria in excess of $100 million but will eventually span about 1 million square feet of production capacity and yield around 100,000 kilograms.” The second project is known as Aphria Diamond, which as they further state is a “joint venture between Aphria and Double Diamond Farms. Aphria is in the process of retrofitting vegetable-growing greenhouses for cannabis production, which saves a lot of time and money as opposed to building a new greenhouse from the ground up. When complete, this 1.2-million-square-foot facility should yield around 120,000 kilograms annually.” This puts Aphria as another perfectly poised stock to take advantage of the changing cannabis market domestically.

The last stock on the list and one that should come as no surprise is the company Aurora Cannabis (NASDAQOTH:ACBFF)  As the last of the big players in the Canadian cannabis space, the company is on track to produce more cannabis annually than any other producer in the world. The company is slated to produce as much as 570,000 kilograms of cannabis per year, which puts them in the top tier of growers throughout the whole of the industry. Aurora has also been working to create series of new products that will allow them to have higher margins than most other cannabis companies. The growing market on oils, concentrates and other products using cannabis as the base, has become a significant portion of the cannabis space overall.

Continue reading
  4 Hits
  0 Comments
4 Hits
0 Comments

The Next Big Thing In Cannabis: Tourism - Cannabis News

Cannabis tourism is growing at a fast clip, drawing thousands of people — and millions of dollars — to states where adult use of cannabis is legal.

In May, women of all ages and occupations gathered south of San Francisco for a weekend of yoga, educational classes, spa treatments — and unlimited cannabis in every form imaginable, including smoothies, body creams and vapes.

The so-called “cannabis tourists” came from all over the world to experience a Ganja Goddess Getaway, a wellness retreat designed for women who already love cannabis, as well as those who want a safe space to try it for the first time.

Click here to read the complete article

Nick Kovacevich ~ Forbes.com ~

Original link
  7 Hits
  0 Comments
7 Hits
0 Comments

Marijuana Stocks Newsletter – Friday August 17, 2018

MJStocks Friday Update- 8/17/2018!

Ready For Canada’s Green Rush?A financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company has put its wheels in motion & that could mean big potential aheadClick Here For More Information

One Company On The Verge Of A Breakthrough? This company has added an ALL-STAR management roster, increased the strength of its board and received positive results on clinical trials…So what are the next steps for this company?Click Here For More Details

Shifting Investment Strategies in the Cannabis MarketThe cannabis industry has been filled with a large amount of opportunity for some time now, but new stocks and news continues to fuel the market with even more propensity toward the future. As laws continue to change and the public perception of cannabis continues to shift, it seems that now is a better time than ever to get involved. Several stocks in the industry have continued to shine as strongholds in their respective fields and as the market is fueling more growth, so are the stocks. More Details Here

Disclaimer: An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by GT Biopharma Inc. for a period beginning July 16, 2018 and ending August 16, 2018 to publicly disseminate information about (GTBP). We own zero shares. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018 NOW EXTENDED TO 8/31/2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Shifting Investment Strategies in the Cannabis Market

The cannabis industry has been filled with a large amount of opportunity for some time now, but new stocks and news continues to fuel the market with even more propensity toward the future. As laws continue to change and the public perception of cannabis continues to shift, it seems that now is a better time than ever to get involved. Several stocks in the industry have continued to shine as strongholds in their respective fields and as the market is fueling more growth, so are the stocks.

The company Canopy Growth Corp. (NYSE:CGC) is a perfect example of a stock in the cannabis market. The company was one of the first pure-play cannabis stocks to be listed on the NYSE back in May and since then, has received a large amount of investments and notoriety. Recent news has shown that CGC received a $4 billion investment from the company Constellation Brands (NYSE:STZ), which will likely help them to move to the top of the cannabis space. According to one report on the company “The company owns and operates many brands, producing and marketing both medical and recreational strains. ‘Tweed’ is one of the company’s most popular brands on account of its association with rapper turned marijuana entrepreneur Snoop Dogg. For the fiscal year ended March 31. 2018, the company reported revenue of CAD 77.9 million or nearly $60 million.” All in all, Canopy remains one of the big players to watch as the market grows.

Aurora Cannabis (OTC: ACBFF  ) has been another one of the big players in the cannabis market for some time now. As one of the big Canadian cannabis companies, Aurora recently hit the news when acquiring the company MedReleaf as the largest deal in the cannabis industry at the time. The pair together are expected to produce as much as 570,000 kg of cannabis per year through nine various facilities in and around Canada. The company has also been working as one of many, to begin operations in the abroad market in places like Denmark and Germany. Many companies in the industry have begun to do this which should solve any worries regarding overproduction in the space overall. With a market cap of over $4 billion, it seems as though Aurora is here to stay for the long haul.

The company the Cronos Group (NYSE: CRON) is a cannabis stock that should also be a household name by this point as they are one of the largest producers of cannabis in Canada. According to one report “ It ships its products to Germany, is building a facility in Israel and has a license through a joint venture in Australia. While it does not have a presence in the United States due to the uncertainty in regulations, as of the fiscal year ending March 31, 2018 the company generated $2.2 million in revenue.” The Cronos Group remains another stock to watch as the industry continues to grow throughout the coming years.

The last stock on the list is the company Marapharm Ventures (MRPHF). The company has been working as a “public company which invests in health and wellness, including medical and recreational marijuana.” As a smaller guy in the industry, Marapharm has a long way to go, but this is exactly what most investors are looking for in a long-term investment.

Continue reading
  6 Hits
  0 Comments
6 Hits
0 Comments

Marijuana Stocks Continue to Thrive

The market on cannabis has remained extremely lucrative over the course of the past several years, but with new updates to legislation and the changing public perception of cannabis as a medicine, it seems as though cannabis stocks are now seeing their time to shine.

According to one report, the global spending on cannabis is scheduled to grow by as much as 230% to $32 billion by 2020. This number is extremely large considering the market was only at around $9.5 billion as of last year. Much of this money will come from the U.S. as more states continue to legalize the use of cannabis throughout. The only issue here that remains is that of legislation in the industry. The U.S. has been in a constant battle between the federal and state governments for some time now, but as we move into the near future, it seems as though this battle is beginning to settle down and states are becoming more comfortable with allowing the use of the substance.

This year thus far has been quite substantial for the future of the cannabis industry as several companies have begun to list on prestigious U.S. exchanges which has helped with the adoption of the industry as a whole. Although there are some companies that are listed on these major exchanges, the majority of cannabis stocks still remain on the OTC market as penny stocks. This however, should not demote them in the mind of the investor, but rather show the high amount of potential that they have in the future. Debra Borchardt, founder of greenmarketsreport.com stated recently that “Just because a cannabis company is trading on the OTC Markets Group, that doesn’t mean that they’re a sketchy stock, it just only means that it’s the only place that they could go. So there are some good names in the OTC Markets group, so don’t let that scare you away. And having said that, there are some less than stellar names in the New York Stock Exchange trading there.”

The company, The Green Organic Dutchman Holdings (TGOD) has been on the rise for some time now, and is a perfect example of a company with a large amount of opportunity for the future. The company has seen its shares rise by as much as 57% in the last few months, which is a normal practice in the cannabis market as big news continues to hit.

Another stock that has brought many investors into the space has been Leafbuyer Technologies Inc. ( LBUY ). Leafbuyer is an online resource for those looking to purchase cannabis or learn about the industry in general. The company has seen its traffic increase by very substantial amounts, making Leafbuyer a very solid place to start when looking at the cannabis market.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

Aurora Cannabis Inc. (ACBFF) Obtains Receipt of Australis Capital Final Prospectus

Aurora Cannabis Obtains Receipt of Australis Capital Final Prospectus and Provides Update With Respect to Australis Distribution to Aurora Shareholders

Aurora Cannabis Inc. (“Aurora” or the “Company”) (ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) today announced, in connection with the spin-out of its subsidiary Australis Capital Inc. (“Australis”), Australis has received a receipt for its final prospectus dated August 14, 2018 (the “Final Prospectus”). The Final Prospectus was filed with the securities regulatory authorities in all provinces and territories of Canada and is available under Australis’ SEDAR profile at www.sedar.com. Receipt of the Final Prospectus will permit Aurora’s Board of Directors (the “Board”) to set the Record date of the transaction, which the company expects the Board will announce within the coming days.  Additionally, Australis received conditional approval to list its shares and warrants on the Canadian Securities Exchange (“CSE”), as well as completed an oversubscribed private placement for proceeds of $17 million .

Australis Capital

Australis will identify and invest in U.S. cannabis and real estate assets. Investments may include and are not limited to equity, debt or other securities of both public and private companies, financings in exchange for royalties or other distribution streams, and the possible acquisition of certain entities. Investments will be reviewed on an on-going basis to determine the appropriateness of their weighting within the greater portfolio, at least monthly and more often as required to provide optimal returns and grow shareholder value. Australis’ stringent investment criteria for growth will maximize returns to shareholders, while focusing on significant near and mid-term opportunities with a commitment to governance and community. Australis’ Board, Management and Advisory Committee have material experience with, and knowledge of, the U.S cannabis space and expect to execute successfully with accretive deals in the near term.

Management Commentary

“The spin-out of Australis delivers additional value to Aurora’s shareholders, while creating a vehicle with considerable upside potential,” said Terry Booth , CEO of Aurora. “Australis provides its shareholders with access to deal-flow in the U.S market, where many successful operators have struggled to access growth capital in an opportunity rich market. With a deeply networked and experienced management team, and a strong balance sheet, Australis is well positioned to capitalize in the U.S. by acquiring attractively priced cannabis assets with high growth potential. The non-brokered, substantially oversubscribed private placement that Australis recently completed to fuel its growth is a reflection of investor appetite for access to U.S. cannabis assets, while recognizing the Australis team’s domain expertise and successful track record of operating in highly regulated and rapidly evolving industries. We look forward to providing additional updates shortly on our progress towards the distribution.”

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

Parent of Corona beer bets $3.8 billion on U.S. love of marijuana - Cannabis News

Constellation Brands Inc., which for seven decades has made its money off beer, wine and whiskey, sees its future in a marijuana leaf.

In the biggest (legal) marijuana deal, the Victor, N.Y., beverage company will spend about $3.8 billion to boost its stake in Canadian grower Canopy Growth Corp., betting legalization will gain traction around the world and especially in the United States.

“This is rocket fuel,” Canopy Chief Executive Bruce Linton said on the company’s earnings call Wednesday. “We’re going to be way more global.”

Click here to read the complete article

Kristine Owram, Jen Skerrit and Craig  Giammona ~ Bloomberg via LATimes.com ~

  Original link
  10 Hits
  0 Comments
10 Hits
0 Comments

Marijuana Stocks Newsletter – Thursday August 16, 2018

MJStocks Thursday Update- 8/16/2018!

GTEC Holdings Ltd.(GTEC) (GGTTF) Extraction Facility on Track for 2019GTEC Holdings Ltd. (GTEC.V) (GGTTF) (“GTEC” or the “Company”), is pleased to provide an update on its wholly owned subsidiary, Spectre Labs Inc. (“Spectre Labs” or “Spectre”). Spectre Labs’ Acceptance of Application for a Controlled Drugs and Substances Dealer’s Licence was received by Health Canada on July 07, 2018 and accepted for review on July 17, 2018 . From the time of receipt of a complete application, the Controlled Drugs Section commits to a service delivery standard of 180 business days for the issuance of a decision on an application for a new Dealer’s Licence for controlled substances.

More Details Here

MJStocks Update On GT Biopharma Inc. (GTBP) The company has added an ALL-STAR management roster, increased the strength of its board and received positive results on clinical trials…So what are the next steps for this company?Click Here For More Details

Ready For Canada’s Green Rush?A financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company has put its wheels in motion & that could mean big potential aheadClick Here For More Information

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

GTEC Holdings Ltd.(GTEC) (GGTTF) Extraction Facility on Track for 2019

GTEC’s Extraction Facility on Track for 2019GTEC Holdings Ltd. (GTEC.V) (GGTTF) (“GTEC” or the “Company”), is pleased to provide an update on its wholly owned subsidiary, Spectre Labs Inc. (“Spectre Labs” or “Spectre”).

GTEC previously announced that it had acquired a warehouse located in Kelowna, B.C. for the purpose of submitting an application to the Office of Controlled Substances for a Dealer’s Licence. The site will be developed in a phased approach and will serve as a Good Manufacturing Practices (GMP) grade facility with extraction, formulation, compounding and export capabilities to support GTEC’s Licensed Producers and the global medical market. GTEC also intends to utilize this facility to manufacture edible products that are expected to be incorporated into Health Canada’s regulatory framework in 2019. Upon Health Canada approval of phase one, the facility will be capable of producing up to 24,500 grams of cannabis oil per day (equivalent to more than 8,500 kilograms per annum), with capacity to increase production through future phased development.

Spectre Labs’ Acceptance of Application for a Controlled Drugs and Substances Dealer’s Licence was received by Health Canada on July 07, 2018 and accepted for review on July 17, 2018 . From the time of receipt of a complete application, the Controlled Drugs Section commits to a service delivery standard of 180 business days for the issuance of a decision on an application for a new Dealer’s Licence for controlled substances.

“We are excited to be making positive progress at Spectre, which will be a cornerstone facility within GTEC’s vertically integrated cannabis supply chain. Given the success and timeline of Zen Labs receiving its license in a timely manner, we remain confident that Spectre’s licensing process will reflect our regulatory team’s efforts.” stated Norton Singhavon, Chairman & CEO of GTEC.   “The Spectre facility will allow us to compete in a broad range of value-added cannabis market segments”.

About GTEC Holdings Ltd.

GTEC was founded in 2017 to capitalize on opportunities in the nascent and rapidly growing legal cannabis industry.   GTEC is focused on growing premium quality craft cannabis in purpose-built indoor facilities.  The Company also has a number of retail cannabis initiatives in Western Canada.   GTEC currently holds a 100% interest in GreenTec Bio-Pharmaceuticals Corp., Tumbleweed Farms Corp., Falcon Ridge Naturals Ltd., Alberta Craft Cannabis Inc., Grey Bruce Farms Inc., Zenalytic Laboratories Ltd. and Spectre Labs Inc.  GTEC is a publicly-traded corporation based in Kelowna , British Columbia.   The Company’s shares are listed on the TSX Venture Exchange and OTC Pink.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

Pure Global Cannabis Inc. (PRCNF) Announces Transformational International Expansion Into Latin America

Pure Global Cannabis Announces Transformational International Expansion Into Latin America/

Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF)  (the “Company” or “Pure Global“), a vertically-integrated, growth-oriented life sciences cannabis company, is pleased to announce that it has entered into a binding letter agreement (the “Agreement“) with Avicanna Inc. (“Avicanna“) to acquire a 60% interest in Avicanna’s Colombian subsidiary, Sativa Nativa S.A.S. (“Sativa Nativa“). In addition, Avicanna will also grant Pure Global an option to acquire an additional 15% in Sativa Nativa for an aggregate ownership of 75%.  Sativa Nativa has been issued a license for the cultivation of psychoactive cannabis and a license for the manufacture of cannabis derivatives by the Colombian Ministry of Justice and Ministry of Health.

Malay Panchal, President & CEO of Pure Global, stated: “This is an exciting day for Pure Global as we make our first entry into Latin America and kickstart our international growth plans. We have found an excellent partner in Avicanna, which has done a tremendous job building highly strategic relationships and assets in Colombia , as well as on-the-ground teams capable of executing our aggressive plans. Sativa Nativa is set to become our flagship international and equatorial asset, which we will leverage to produce low-cost inputs for value-added products destined for emerging export markets.”

Aras Azadian , CEO of Avicanna, commented: “In partnering with Pure Global, we have found a talented and like-minded team focused on bringing science-based innovations to the global cannabis marketplace. We look forward to combining resources and efforts with Mr. Panchal and his team to position Sativa Nativa as an industrial-scale, sustainable and economical producer of cannabinoids for international markets.”

Highlights of the Transaction

International expansion for Pure Global into emerging Latin America cannabis hubEstablish leading state-of-the-art greenhouses on 28 hectares of land, with further potential expansion availableIndustrial-scale production and low-cost cultivation – plans for 1 million square foot state-of-the-art greenhouse in Santa Marta, Colombia with advanced technologies and automation to produce several fold greater than traditional methodsCompetitive cost advantages of cultivation with an estimated cost per gram to be a fraction of Canadian licensed producersStrong partnership with Avicanna which has joint ventures with Grupo Daabon, the largest organic agricultural company in the world, along with admission into Johnson & Johnson Innovation’s JLABS life sciences incubator in Toronto, CanadaProduction capacity is for the cultivation of both high tetrahydrocannabinol (“THC”) content and cannabidiol (“CBD”) cannabis plants

Overview of Sativa Nativa S.A.S.

Continue reading
  7 Hits
  0 Comments
7 Hits
0 Comments

What a $4 Billion Cannabis Investment Means for the Industry

The cannabis industry has been growing for some time now with a massive amount of propensity toward the future. Since the market is still very much in its infancy, any events that occur usually can mean a lot for the whole of the market. The largest piece of news to hit as of recent has been the investment from Constellation Brands (NYSE:STZ) into Canopy Growth Corporation (NYSE:CGC) This investment equalling over $4 billion, has meant that the stock price for Canopy jumped by around 40% during the beginning of the trading day.

The investment by Canopy is a 51% premium to the closing price of the stop as of Tuesday, but the ownership from Constellation will jump up to almost 40% as opposed to their current 10%.

Wells Fargo analyst Bonnie Herzog stated that “overall, we think Constellation’s increased stake in CGC (the largest investment to date in the cannabis space) is very positive and further accelerates another avenue of growth.” Bruce Linton, the Co-CEO of Canopy stated that Canopy is an important company, of all the Canadian names selling marijuana it refines the product and makes the product into different formulations such as soft gel caps.” This, however, is more than just another investment in the cannabis space, this is an investment on a large scale that adds to the credibility of the cannabis market overall.

The CEO of the company Tilray (TLRY), Brendan Kennedy, stated that “This industry [cannabis] is disrupting the pharmaceutical industry, cannabis is a threat to prescription based painkillers primarily opioids. It’s definitely a threat to companies in the alcohol industry who see cannabis as a substitute — it’s also a threat to some of the functional food and beverage companies who don’t look at THC as an ingredient but look at CBS as an ingredient in CBD water or CBD exercise or recovery drink.” The cannabis industry has a massive amount of potential to disrupt these other large industries by offering a patient a much better alternative to the drugs that exist now.

The cannabis market may have been around for some time now, but most of its history has been filled with a myriad of issues including legislation and some issues with it being adopted by the general public. These issues all, however, seem to be in the process of being ironed out as new companies continue to innovate the space on cannabis. One of the companies that has come in with a new way to connect the consumer with the producers and the local cannabis economy has been Leafbuyer Technologies Inc. (LBUY) Leafbuyer has been a resource for online data for everything a consumer would need to know about the cannabis space. The company has also seen a major increase in its traffic over the past year or so, which is helping to bring in more investors into the cannabis space as a whole.

Continue reading
  6 Hits
  0 Comments
6 Hits
0 Comments

The Reshaping of the California Weed Market

The California weed market is arguably one of the most successful in the world given the length it has been around as well as the sheer size of the industry. When the state decided to implement the use of recreational cannabis throughout the nation back on January 1st, everything in the industry had to change.

Although the Californian cannabis market has been slated to be the largest and fastest growing, things seem to be getting off to a slow start as of now. One of the reasons that this is occurring seems to be the consumers choice to continue utilizing the black market as their resource to buy cannabis and cannabis-related products. The state has decided to fight back on this accord by putting new legislation in place that could effectively help to stimulate the market even further. Lori Ajax, the state’s top marijuana regulator, stated that “unfortunately there is confusion out there.” California has only been selling recreational cannabis for about a few months now, with temporary laws in place to aid sales. Throughout the state, operations are being undergone to produce large and higher amounts of cannabis and various products that use cannabis as their base.

The state recently held a hearing led by Ajax, where those who are involved in the cannabis market got a chance to speak their minds as to what needs to change in order for the industry to finally flourish. One of the main issues with the industry has been the high rate of taxes that have been undergone over the past few months. In some instances, taxes have meant that individuals are paying as much as 50% more for a product that they could buy much cheaper on the black market. These taxes may have started out as a way to entice the legal measures to be put in place, but at this point, it seems to be hurting the market more than anything. Sarah Armstrong of Americans for Safe Access, stated that “the patients are citizens too. They have rights and they have needs.” These need to not seem to be met by the state, and therefore a large amount of complaints are being made about what should be a very smooth running industry.

One of the aspects that has caused costs for producers to rise has been the issue of packaging. New state laws have rightfully gone into place that make it so packaging needs to be very explicitly childproof. Although this is of course a necessity, it seems as though this may be hurting the profits in the short run and in turn passing on these costs to the consumer. In order for the California cannabis market to continue to flourish, several aspects need to be ironed out. The first is the high tax rates that were mentioned prior. If patients are able to find cannabis that is competitively priced with the black market on cannabis, they may be more willing to switch over. The only issue in the market seems to be with that of price and how much the legality of cannabis is adding to the final price and cost of the goods.

The cannabis market, however, is still very much in its infant stage due to how new it is overall. The hopes are high that over the course of the next few years, companies will be able to iron out these issues with the government so that they can continue to offer high quality and low cost cannabis to patients and consumers alike in the space.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

Canada: 'A moment in history': Hundreds turn out for Calgary cannabis job fair - Cannabis News

Job seekers from in and around Calgary lined up to hand in their resumes Tuesday for an opportunity to work in the cannabis industry, as new retail company 420 Premium Market held a job fair at the BMO Centre at Stampede Park.

Jeff Mooij, president of 420 Premium Market, says his company is looking for approximately 420 new employees to be trained and ready when they open their doors Oct. 17, when recreational marijuana becomes legal in Canada.

“This is the first time that we get to see the new people who are going to join our culture, so it’s super exciting,” says Mooij.

Click here to read the complete article

Dean Pilling and Anna Junker ~ CalgaryHerald.com ~ 

Continue reading
  11 Hits
  0 Comments
11 Hits
0 Comments

Marijuana Stocks Newsletter – Wednesday August 15, 2018

Next Steps For GT Biopharma Inc. (GTBP) The company has added an ALL-STAR management roster, increased the strength of its board and received positive results on clinical trials…So what are the next steps for this company?Click Here For More Details

Ready For Canada’s Green Rush?A financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company has put its wheels in motion & that could mean big potential aheadClick Here For More Information

Constellation Brands (STZ) to Invest $5 Billion CAD in Canopy Growth (CGC) to Establish Transformative Global Position and Alignment Constellation Brands (STZ) (STZ-B), a leading beverage alcohol company, and Canopy Growth Corporation (Canopy Growth) (WEED.TO) (CGC), a leading diversified cannabis company (together, the “Companies”), today announced a significant expansion of their strategic partnership to position Canopy Growth as the global leader in cannabis production, branding, intellectual property and retailing. More Details Here

The Green Organic Dutchman Holdings Ltd. (TGOD) (TGOD.F) Reports Q2 ResultsAs TGOD prepares for the launch of its high quality, consumer-preferred premium organic brand, the Company will continue to focus on R&D to develop innovative cannabis consumer products for both the medical and recreational markets. The Company’s patient database continues to experience significant month over month growth as TGOD’s brand of organically-certified cannabis continues to gain increased recognition. The back-office ecommerce network agreement with Shopify has been consummated, and TGOD continues to develop a robust ecommerce platform to support domestic and international expansion. More Details Here

GTEC Holdings Ltd. (GTEC) Hires Alcoholic Beverage Industry Veteran as Global Marketing & Branding Director

Continue reading
  13 Hits
  0 Comments
13 Hits
0 Comments

GTEC Holdings Ltd. (GTEC) Hires Alcoholic Beverage Industry Veteran as Global Marketing & Branding Director

GTEC Holdings Hires Alcoholic Beverage Industry Veteran as Global Marketing & Branding Director

GTEC Holdings Ltd. (GTEC.V) (GGTTF) (“GTEC” or the “Company”) is pleased to announce that Lawrence Law has been appointed as GTEC’s Global Marketing & Branding Director. Mr. Law was previously employed at Diageo plc (“Diageo”), the world’s largest alcoholic beverages company.

At Diageo, Mr. Law was Global Brand Director for Johnnie Walker’s Blue Label and Super Premium Portfolio. He was accountable for building a premium brand strategy, revenue performance and growth of Johnnie Walker’s Luxury Portfolio globally. During his 10-year tenure at Diageo, he spearheaded multiple pioneering marketing and product innovations including Johnnie Walker’s Luxury Retail Experiences, Digital Product Personalisation and the Casks of Distinction Single Malts Program.

Lawrence brings a vast amount of advisory experience working with clients from all sectors including banking, automotive, technology and luxury sectors, where he built a broad range of deep marketing skills across multi categories and business functions. The future adult-use market can pivot into many different directions including opportunities and partnerships in the pharmaceutical, alcohol, and tobacco space. Lawrence’s wide range of sector experience, especially in a highly regulated and competitive market, will be vital in shaping GTEC’s branding strategy.

“I’m very excited to be part of this new game changing category and even more excited to be part of GTEC’s ambition and purpose,” said Lawrence Law .

“We are very pleased to have Lawrence join our team,” said Norton Singhavon, Chairman and CEO of GTEC. “With GTEC’s focus on premium quality craft cannabis, we are confident that he will play a key role in the future development of our premium retail brands and products.”

Continue reading
  11 Hits
  0 Comments
11 Hits
0 Comments

Marapharm Ventures Inc. (MRPHF) Updates Shareholders on Licensing in Nevada

Marapharm Ventures Inc. Updates Shareholders on Licensing in Nevada

Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) (“Marapharm” or the “Company”) updates shareholders on its proceedings to establish jurisdictional licensing in preparation for the sale of cannabis, once in full production.

As reported by news release on July 27, 2018 , cultivation in our temporary buildings continues, allowing us to maintain our production schedule.  Contractors are working with the City of North Las Vegas and the State of Nevada to meet the necessary requirements for the Certificate of Occupancy’s. This will permit the Tax Department’s final inspection and the transfer of plants to the new facilities.

On June 22, 2018 , Marapharm applied for three City of Las Vegas Business Licences. The Company is pleased to report that after an in-depth application and interview process, which typically takes several months, the City of Las Vegas expedited our three 90-Day Temporary Conditional Licences for Econevada and Phenofarm on August 2, 2018 .

These licences permit the distribution of cannabis from our facilities in North Las Vegas to dispensaries in the Las Vegas metropolitan area which in 2017, saw spending estimated at $34.8 billion by more than 42 million visitors. The year-to-date as at June 2018 showed visitor numbers over 21 million. www.lvcva.com

On July 5, 2018 , the State of Nevada , Department of Taxation issued a notice seeking applications from qualified applicants to award recreational marijuana retail store licenses. The number of available licences is limited. The Company is qualified to apply for up to 3 retail store licenses in Las Vegas and surrounding jurisdictions.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Constellation Brands (STZ) to Invest $5 Billion CAD in Canopy Growth (CGC) to Establish Transformative Global Position and Alignment

Constellation Brands to Invest $5 Billion CAD in Canopy Growth to Establish Transformative Global Position and Alignment

 Constellation Brands (STZ) (STZ-B), a leading beverage alcohol company, and Canopy Growth Corporation (Canopy Growth) (WEED.TO) (CGC), a leading diversified cannabis company (together, the “Companies”), today announced a significant expansion of their strategic partnership to position Canopy Growth as the global leader in cannabis production, branding, intellectual property and retailing.

Constellation Brands will increase its ownership interest in Canopy Growth by acquiring 104.5 million shares directly from Canopy Growth, thereby achieving approximately 38 percent ownership when assuming exercise of the existing Constellation warrants.  Constellation Brands is acquiring the new shares at a price of C$48.60 per share, which is a 37.9 percent premium to Canopy’s 5-day volume weighted average price of the common shares on the Toronto Stock Exchange (“VWAP”), and a 51.2 percent premium to the closing price on August 14, 2018.  Constellation will also receive additional warrants of Canopy that, if exercised, would provide for at least an additional $4.5 billion CAD to Canopy Growth.

As a result of the new shares Constellation is acquiring, Canopy Growth will immediately upon closing have proceeds of approximately $5 billion CAD [$4 billion USD] to bolster its leadership position in the global cannabis industry.  This investment, the largest to date in the cannabis space, will provide funds which Canopy Growth will deploy to strategically build and/or acquire key assets needed to establish global scale in the nearly 30 countries pursuing a federally permissible medical cannabis program, while also rapidly laying the global foundation needed for new recreational cannabis markets.  Canopy Growth’s Canadian platform does not require additional cannabis cultivation assets, and management views other jurisdictions, including the United States, as strategic priorities requiring significant capital.

“Through this investment, we are selecting Canopy Growth as our exclusive global cannabis partner,” said Rob Sands, Chief Executive Officer, Constellation Brands.  “Over the past year, we’ve come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy’s market-leading capabilities in this space.  We look forward to supporting Canopy as they extend their recognized global leadership position in the medical and recreational cannabis space.”

Canopy Growth will benefit from Constellation’s deep understanding of consumer trends and shifting preferences, and proven ability to translate those insights into distinct brand positionings that build strong connections with consumers and foster brand loyalty.  Constellation’s disciplined approach and capabilities in areas such as mergers and acquisitions, finance, large-scale production, marketing and sales as a leading Fortune 500 company, combined with Canopy’s entrepreneurial approach and best-in-class knowledge and expertise within the emerging cannabis sector create a powerful combination that will ensure Canopy Growth is set up for sustainable, long-term success as the company and sector evolve.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Marijuana Stocks On the Rise

The cannabis industry has been moving forward with a massive amount of propensity toward the future for some time now, but several stocks have been heading to the forefront of the industry due to their unique offerings.

The first company on the list and one that should come as no surprise is the company Canopy Growth Corp (NYSE:CGC). With a market cap of over $5 billion, the company is widely regarded as one of the top marijuana stocks in the industry. The company according to one report “engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, soft gel capsules, and hemp. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.” The company has also been working to move their operations into various markets abroad. This is poised to help with any worries of overproduction that may have been feared in the past. For any investor in the cannabis market, Canopy Growth should be of high consideration.

The next company on the list and one that prides itself as being a part of the ancillary industry on cannabis is the company Kush Bottles (OTC:KSHB). Kush Bottles is a company that according to one report “is a dynamic sales and distribution platform that provides unique products and services for both businesses and consumers in the cannabis industry.” One of the most enticing parts of Kush Bottles is the fact that they have a perfect amount of exposure to the cannabis industry without all of the risk of being part of the pure-play marijuana industry. Kush Bottles has been responding to a large amount of package regulations put into the market by producing new types of child-proof packaging for cannabis-related products.

The company Aphria (OTC:APHQF) is another one of the larger companies in the cannabis space with a market cap of around $1.7 billion and a share price of about $7.60. According to one report “Aphria Inc., is one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available.” The company has been working to give very high-end cannabis for low prices to the consumer market, which is poised to continue growing. As Canada puts recreational cannabis in place by October 17th, Aphria seems as though they could potentially be one of the largest gainers in the market.

The last stock on the list is the company Leafbuyer Technologies Inc (LBUY)Leafbuyer is a company that has been working to compete in the online cannabis resource community. The company helps consumers direct their purchases to the right place as well as give them the proper information on the products they are getting.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

The Green Organic Dutchman Holdings Ltd. (TGOD) (TGOD.F) Reports Q2 Results

The Green Organic Dutchman Reports Q2 ResultsThe Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TGOD.TO) (US: TGODF) reported its financial and operational results for the second quarter of fiscal 2018, ended June 30th, 2018. These filings are available for review on the Company’s SEDAR profile at www.sedar.com.

HighlightsThe Company:

continued to make strong progress on the construction of its facilities in Ancaster, Ontario and Valleyfield, Quebec, spending a total of $20,734,000 on those initiativesreceived organic certification from ECOCERT Canadasuccessfully completed the record breaking Initial Public Offering on the Toronto Stock Exchange, raising gross proceeds of $132,264,000expanded its shareholder base from 4,000 to over 20,000announced a strategic partnership agreement with Epican Medicinals Limited, a vertically integrated Jamaican cannabis companycompleted a letter of intent with Denmark’s Queen Genetics/Knud Jepsen A/S, which, if completed will increase TGOD’s total organic-funded capacity to 195,000 kgsannounced several strategic licensing agreements with top US brands including Stillwater Brands, Evolabs, and CBx Sciencescompleted a $25,024,000 bought deal financing which closed on June 26th, 2018

The overall construction in Ancaster, Ontario and Valleyfield, Quebec remains on schedule with cultivation expected to commence in the first half of 2019. The Company maintained a strong balance sheet with cash and cash equivalents of $261,816,000 and continues to execute on management’s vision of becoming the largest organic cannabis brand in the world.

TGOD is moving forward at a rapid pace on its aggressive, de-risked business plan and continues to significantly expand all aspects of its business. Cash used in operating activities equated to $7,196,000 for the three months ended June 30, 2018. This spend included strategic initiatives in consumer market research, marketing and brand building in anticipation of the Company’s launch into the recreational market. TGOD has also committed to investing in research and development initiatives which are expected to bring new technologies to commercialization. The Company has prioritized hiring highly skilled and experienced staff while investing in infrastructure to rapidly scale its business.

As TGOD prepares for the launch of its high quality, consumer-preferred premium organic brand, the Company will continue to focus on R&D to develop innovative cannabis consumer products for both the medical and recreational markets. The Company’s patient database continues to experience significant month over month growth as TGOD’s brand of organically-certified cannabis continues to gain increased recognition. The back-office ecommerce network agreement with Shopify has been consummated, and TGOD continues to develop a robust ecommerce platform to support domestic and international expansion.

“We are pleased with the accomplishments we have made in such a short period of time. We have invested heavily in building the foundation to drive our Company forward at an unparalleled pace,” said Brian Athaide, TGOD’s CEO. “Construction is on schedule across all jurisdictions and we continue to aggressively build our medical and adult-use brand. TGOD is investing heavily in consumer research, R&D and simultaneously building both the capability and systems needed to rapidly scale as we prepare for the adult-use market,” continued Athaide.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

The Best Performing Cannabis Stocks During the Month of August

The cannabis market has remained extremely lucrative for some time now, but August has been a month in waiting for the upcoming recreational market to take place next month in Canada. As stocks around the industry ready themselves for this new and high demand period, it seems as though now is a better time than ever to get involved in the cannabis space.

One of the companies that many have been watching and one that remains quite large in the market is the company Insys Therapeutics (NASDAQ:INSY). The company currently has a market cap of around $560 million and a share price that still remains relatively low at around $8. According to one report “It is also developing Cannabidiol Oral Solution, which has completed a pediatric study for the treatment of pediatric epilepsy; has completed Phase II study to treat west syndrome; and is in Phase II study for the treatment of childhood absence epilepsy, as well as Buprenorphine Sublingual Spray that has completed Phase III study to treat acute pain.” Only a few key players in the cannabis space have been working to get their cannabis-based pharmaceuticals approved by federal agencies, but this seems to be an increasing part of the overall market share.

The next company on the list is the company CannTrust Holdings (NASDAQOTH:CNTTF). CannTrust has been one of the major Canadian marijuana producers and one of the only companies in the space that has reported three consecutive profitable quarters. According to one report “CannTrust already has two production facilities that together have close to 500,000 square feet of growing space. The company has also started construction of an even larger facility. When this facility is ready, CannTrust will have total annual production capacity of more than 100,000 kilograms.” This amount of production is quite large in the way of the cannabis market, and as stated before, could help to deal with the new and high demand for cannabis throughout Canada. One of the ways that companies are working to defeat any potential of an oversupply is through the use of export. Companies are working to export their products into abroad markets such as that of Germany and beyond which will likely help their profits as well. The company according to the same report already has “supply agreements for recreational marijuana with three provinces — British Columbia, Alberta, and Manitoba.” For this reason, CannTrust seems to be poised perfectly to continue taking advantage of the growing cannabis space.

The last company on the list is the company Marapharm Ventures (MRPHF) Marapharm Ventures according to one report “is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.” The company is also in the right spot to take advantage of the fast-paced cannabis market in the coming years.

The hopes are high that the companies mentioned above can continue to perform well as the next months and years fly by.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

Sacramento to Help Ex-Convicts Break into the Weed Industry

Last week, the Sacramento City Council officially approved its plan to reduce drug crime by announcing its CORE program to help ex-convicts run their own, legal cannabis businesses.

It’s no secret that marijuana means big bucks in society today. The drug’s annual revenue in the United States has soared to multibillion-dollar status and continues to steadily grow. In California, the recreational market is expected to hit $3.7 billion by the end of this year after only opening in January. By 2019, that number is projected to reach $5 billion. Those numbers are enticing to anyone, but not everyone has been able to penetrate the market. Those who have been convicted for drug-related crimes, for instance, have been repeatedly excluded when it comes to the booming industry. Thus, creating a glass ceiling in this relatively new industry.

“The same people who have imprisoned us are now the same ones who are taking advantage of the decriminalization of marijuana,” Rashid F. Sidqe, vice-chair of Sacramento’s Law Enforcement Accountability Directive, told CBS 13 in Sacramento.

Just a few years ago, marijuana was something that landed these individuals in jail, but now people are seeking tremendous success from it. Despite the drug’s decriminalization, many of these ex-convicts are continually ostracized from taking part in marijuana’s immense profitability. Sacramento, however, seeks to change all that via an equal opportunity program. Officially, it is called the Cannabis Opportunity Reinvestment and Equity (CORE) program. CORE was first approved last November and was met with initial resistance from people who were uncomfortable with having marijuana businesses in their neighborhoods. Last week, it was officially approved. City Council was able to identify eight neighborhoods affected by the 40-year-long war on drugs via its police department’s Crime Analysis Unit. It was then discovered that these neighborhoods had suffered disproportionate marijuana-related arrests from 2004 to 2017.

To combat this issue, City Council concluded that those who have lived in these eight neighborhoods for at least five years could receive benefits. Anyone who was arrested for nonviolent marijuana crimes between 1980 and 2011, or who had an immediate family member convicted for cannabis during that time, qualifies for the program. These benefits will wave business permit fees that can reach to tens and thousands of dollars, expunge these marijuana arrests from their criminal records, give these individuals priority access into the cannabis business, and give them the opportunity to be mentored by industry experts.

Continue reading
  11 Hits
  0 Comments
11 Hits
0 Comments

Marapharm Ventures Inc. (MRPHF) Announces Board Change

Marapharm Ventures Inc. Announces Board Change

Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) (“Marapharm” or the “Company”) a public company with substantial medical and adult-use cannabis assets in the United States and Canada is very pleased to announce the appointment of Mr. Rahim Mohamed to serve on the board of directors.

Mr. Rahim S. Mohamed currently serves as CEO of APPx Crypto Technologies Inc., a reporting issuer company developing a retail loyalty platform called CatchCoin and APPxPay.  APPx Crypto Technologies Inc. also mines cryptocurrency, bitcoin and altcoins, including Bitcoin Cash, Ether, and Litecoin. In addition, the company develops custom blockchain solutions that protect users and businesses. Mr. Mohamed has also served in the capacities of President, CEO and Internal Auditor for multiple private and public companies.

For several years Mr. Mohamed was General Manager at IR Consultants Inc. in Calgary, Alberta where he provided expertise in handling major investor relations and media relations and financings with subject matter experts and key decision-makers at all levels of matrixed organizations. He received his Exempt Market Products Certification in 2010 and is a current member of the Exempt Market Dealers Association of Canada.

Mr. Mohamed currently sits on the boards of APPx Crypto Technologies Inc, and AGAU Resources Inc. He holds a degree in (Management) Commerce from AthabascaUniversity in Calgary.

He has a solid background in the development and execution of successful strategic communication plans, high-impact communication initiatives and effective operational processes for the rapid delivery of corporate alignment and improvements

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

Future Farm Technologies Inc. (FFRMF) Closes on Acquisition of 50% Interest in CEPG Consulting and Design Inc.

Future Farm Closes on Acquisition of 50% Interest in CEPG Consulting and Design Inc.; Now Ready to Apply for a Dealer License in Canada

Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQX: FFRMF) is pleased to announce that it has completed its acquisition of a 50% interest in CEPG Consulting and Design Inc. (“CEPG”) of St. John’s, Newfoundland. CEPG will participate in the cannabis and hemp breeding program under the previously announced joint venture between Future Farm and Rahan Meristem Ltd. (“Rahan”), a world renowned global agro-biotechnology company based in Israel. The joint venture will operate out of both an existing building to be transferred to CEPG by Snellen Holdings (1994) Co. Ltd. (“SHC”) and 6,000 square feet of newly constructed laboratories.

CEPG is a Canadian corporation which, until the closing of Future Farm’s acquisition of 50% ownership, was wholly owned by SHC, also based in St. John’s. SHC has been developing controlled environment plant growth systems since 1981.

CEPG will apply for a dealer license from Health Canada, which will enable research and development to begin on the growth of cannabis plants. Once licensed, the R&D facility will use state-of-the-art controlled environment equipment and techniques to create a research hub for the Rahan and Future Farm JV, which is expected to create valuable IP to be sold or licensed worldwide. The joint venture will develop, own and utilize Rahan’s proven and proprietary technology to mass-produce elite new strains of marijuana to fit various profiles required of the medical and legal use of this highly valuable and beneficial plant.

“Now that we are 50% partners with Future Farm, we can fast-track the build-out of our lab space,” comments Chris Snellen, President of CEPG. “In the meantime, we hope to outsource initial analytical and tissue culture work to Memorial University of Newfoundland and even partner with them on several R&D projects.”

As part of the JV, Rahan shall be responsible for providing the know-how and technology, as well as management and operation of the breeding program.

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

Aurora Cannabis Inc. (ACBFF) and Alcanna Applaud Ontario Government Decision to Open Province to Private Retail of Cannabis

Aurora Cannabis and Alcanna Applaud Ontario Government Decision to Open Province to Private Retail of Cannabis

Aurora Cannabis Inc. (“Aurora”) (ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) and Alcanna Inc. (“Alcanna”) (CLIQ.TO) applaud the Ontario Government on its new plans for the responsible sale of recreational cannabis products through government-operated online sales, and the private sector.

Aurora and Alcanna have entered into a license agreement which – as soon as regulations permit – will allow Alcanna to open retail cannabis stores under the brand name “Aurora”. Alcanna has made considerable progress in preparing for this exciting opportunity and has identified over 100 potential retail locations throughout the province already. This agreement represents a significant competitive advantage and will allow for the rapid establishment of a robust network of cannabis retail stores that comply with all provincial and municipal requirements, making product, consumer and public safety a top priority.  Together, the two companies have the technology, relationships, and supply chain and retail expertise to quickly establish a full network of stores across the province as soon as they are permitted.

“Allowing a private retail channel in Ontario for recreational cannabis is good news for industry, consumers, and taxpayers, and will go a long way to making a meaningful impact on the grey market,” said Aurora CEO Terry Booth . “It’s the right thing to do, and we commend Premier Ford and his government for taking this bold step. Through Alcanna, the nation’s largest private retailer of a controlled substance, we will leverage long-standing relationships with landlords, regulators and other stakeholders, and through superior capitalization, we will rapidly establish a significant presence in the province.”

“Alcanna has made considerable progress in preparing for this exciting opportunity. We started leveraging our existing relationships with commercial landlords across Ontario the day after the June 7 th election. We have identified over 100 potential retail locations throughout the province already, and we will be ready to go with fully functional stores as soon as we are permitted,” said James Burns , CEO of Alcanna. “For the last six months, our expert teams in store development, merchandising, training and product knowledge have been working steadily toward bringing the first cannabis retail stores to life in Alberta . We’re thrilled about the prospect of bringing that expertise to Ontario and will open as many stores as the government will allow after April 1, 2019 .”

Aurora and Alcanna will reimagine the customer retail experience with fully immersive, state-of-the-art stores that offer an inviting and educational brand experience. Highly trained Category Specialists will engage new and experienced customers with superior product knowledge and socially responsible advice.

Continue reading
  12 Hits
  0 Comments
12 Hits
0 Comments

Marijuana Stocks Newsletter – Tuesday August 14, 2018

GT Biopharma Inc. (GTBP) Announces CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare ConferenceGT Biopharma Inc. (GTBP), an immuno-oncology biotechnology company focused on innovative treatments based on the company’s proprietary platforms, announced today the Chief Executive Officer, Dr. Raymond W. Urbanski, will present at the Wedbush PacGrow Healthcare Conference on Wednesday, August 15, at 1:50pm.Click Here For More Details

Will Canada Produce The Next Green Rush?A financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company has put its wheels in motion & that could mean big potential aheadClick Here For More Information

Different Ways to Invest in the Booming Cannabis SpaceThe cannabis market has managed to stay one of the most interesting spaces for financial investment over the past several years, but new updates to the industry continue to bring new opportunity to marijuana. As many states and countries alike begin to legalize the use of cannabis, many companies are working to create new and innovative businesses. These new companies have helped to form a solid base for investors to look at when viewing the marijuana stock market. Over the past few years, several new ways have come to light in terms of how to invest in such a rapidly growing industry.

More Details Here

Disclaimer: An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by GT Biopharma Inc. for a period beginning July 16, 2018 and ending August 16, 2018 to publicly disseminate information about (GTBP). We own zero shares. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018 NOW EXTENDED TO 8/31/2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

mCig, Inc. (MCIG) Introduces Artax, a New CBD Pet Line, and Launches E-commerce CBD Market

MCIG Introduces Artax, a New CBD Pet Line, and Launches E-commerce CBD Market

mCig, Inc. (MCIG), a diversified company servicing the legal cannabis market, announced today that the company has launched a CBD Pet Products line, Artax, as well as a new e-commerce CBD market, https://www.CBD.Biz/.

“We are excited to launch our premiere CBD product line for pets. These new products have been in the works for some time as we realize the growth of the pet market and its importance to the domestic and international markets,” says Paul Rosenberg, MCIG’s CEO.

 Animal lovers are looking for a natural and safe approach to improving the health and wellness of their pets. Recent research shows steady growth in the pet supplement market, with an anticipated compound annual growth rate of 5% between 2018 and 2022.

The new CBD pet line, Artax, includes organic CBD infused pet treats, oral drops, shampoo, and oral sprays. Expert-crafted formulations are made with premium, human-grade ingredients and organic hemp extract.

“CBD can help animals in many of the same ways that it helps humans: improving arthritis, immunity, anxiety, and digestion, and even with more serious conditions, like broken bones and post-operative care,” says Arkady Uryash, MD, PhD, head of MCIG’s Research and Development Department.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

GT Biopharma Inc. (GTBP) Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare Conference

GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare Conference

GT Biopharma Inc. (GTBP) and (Euronext Paris: GTBP.PA), an immuno-oncology biotechnology company focused on innovative treatments based on the company’s proprietary platforms, announced today the Chief Executive Officer, Dr. Raymond W. Urbanski, will present at the Wedbush PacGrow Healthcare Conference on Wednesday, August 15, at 1:50pm.

Dr. Urbanski’s presentation will provide a corporate overview and highlight the company’s proprietary technology platforms. These innovative platforms include the tri- and tetra-specific natural killer cell engagers (TriKEs and TetraKEs) as well as their bi-specific antibody drug conjugates. In addition, Dr. Urbanski will provide an update to their current clinical and preclinical programs.

Dr. Urbanski said, “We are very excited to present at the Wedbush PacGrow Healthcare Conference. Conferences such as this gives us the opportunity to engage with leading institutional investors and interact with other global companies. It also allows us to further demonstrate that GT Biopharma is at the forefront of immune-oncology therapeutics.”

A webcast of the conference presentation will be available on the company website at gtbiopharma.com after the conference.

Continue reading
  7 Hits
  0 Comments
7 Hits
0 Comments

Aurora Cannabis Inc. (ACBFF) Completes Acquisition of Anandia Laboratories

Aurora Cannabis Completes Acquisition of Anandia Laboratories

Aurora Cannabis Inc. (“Aurora” or the “Company”) (ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) today announced that its acquisition of Anandia Laboratories Inc. (“Anandia”) is now complete. The previously announced arrangement, under the provisions of the Business Corporations Act ( British Columbia ), means that among other things, Aurora has now acquired all of the issued and outstanding shares of Anandia in an all-share transaction (the “Transaction”).

Anandia is a world-leading cannabis-focused science company, specialized in genomics, metabolite profiling, plant breeding, disease characterization, and cultivar certification, as well as providing testing services to producers and patient-cultivators.

Dr. Jonathan Page , co-founder of Anandia, is a globally renowned cannabis scientist, whose 37 peer-reviewed publications include key studies on cannabinoid and terpene biosynthesis. He previously led the Canadian team of scientists who were first to publish the cannabis genome sequence. As a result, Anandia now holds intellectual property with significant commercial value that can be applied towards highly specialized and customized cultivar and product development. Dr. Page is also an accomplished inventor with 8 issued patents or patent applications, and a frequent lecturer on cannabis science at international conferences.

The acquisition of Anandia represents a critical piece of Aurora’s vertical integration strategy – to create a company that captures margin along the entire cannabis industry value chain, enhances cultivation yields to improve financial performance, develops industry-leading intellectual property, and builds a broad portfolio of high value-added products.

In addition to providing strong competitive advantages to Aurora, Anandia provides access to several new revenue streams, delivering services to licensed cannabis producers, such as:

Continue reading
  7 Hits
  0 Comments
7 Hits
0 Comments

The Big Players of Legal Cannabis

The cannabis industry has been booming with a massive amount of propensity toward the future for some time now, but several companies have come to light with large market caps and even larger ideas to completely transform the cannabis space. These higher market cap companies have a large amount of promise due to being leaders in their field respectively, but it does look as though the upside potential has yet to come.

One of the main companies that should come as no surprise is the company Canopy Growth (CGC ). Canopy has been one of the largest cannabis stocks for some time now. One of the most promising aspects of investing in Canopy seems to be the impending legal recreational cannabis that will hit the market in Canada on October 17th. Many have been waiting for this to occur given that a large amount of the cannabis space is still dependent on speculation due to its infancy as a market. The company has also recently announced a partnership with Constellation Brands (STZ) which will likely help them to begin distributing new types of products such as cannabis-infused beverages and more. This could become one of the largest parts of the cannabis industry as a whole in the near future, and is one of the main reasons that so many investors are looking at this company for growth over the next few years.

The next company and one that is a household name by this point is Aurora Cannabis  (ACBFF) The company currently has the second largest market cap of all marijuana stocks which can partly be attributed to their acquisition of the company MedReleaf earlier in this year. The company is an established brand in many countries around the world, and has been a large player in the cannabis growing space for some time now. Aurora has also been working to offer many different services to the cannabis space given their large expertise. Aurora continues to have large growth plans for the future, and investors should continue to watch this company in the coming months to years.

The company GW Pharmaceuticals (GWPH) is a large player in the cannabis space, but not in the traditional sense of the market. GW has been working to get various cannabis-derived drugs approved by the FDA in the U.S. for some time now. The company was the first to receive an FDA approval for a cannabis based drug in the U.S. several months ago, and continue to break ground in new spaces throughout the pharmaceutical uses of the cannabis plant.

The last company on the list is one of the smaller guys in the market, but one with a large amount of promise for the future. Beleave Inc (BLEVF) has been a producer of medical cannabis in Canada for a few years now. The company states that they are a licensed Canadian biotech company and states further that their “larger strategy is to obtain cultivation and sales licenses and build out North American and European distribution channels. Beleave then hopes to expand production and capitalize on expected demand-growth spurred by cannabis legalization across Canada and in select US states.” Beleave remains a company with a large amount of potential for the coming years.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

Different Ways to Invest in the Booming Cannabis Space

The cannabis market has managed to stay one of the most interesting spaces for financial investment over the past several years, but new updates to the industry continue to bring new opportunity to marijuana. As many states and countries alike begin to legalize the use of cannabis, many companies are working to create new and innovating businesses. These new companies have helped to form a solid base for investors to look at when viewing the marijuana stock market. Over the past few years, several new ways have come to light in terms of how to invest in such a rapidly growing industry.

One of the best and most consistent ways to invest in the cannabis market has been through the investments in the growing part of the industry. This may seem like the most straightforward method to investing, but it has managed to remain lucrative for some time now. Organigram Holdings (NASDAQOTH:OGRMF) is based out of New Brunswick, and has been a large producer of the raw cannabis plant for some time now. According to one report “OrganiGram substantially increased its annual peak production capacity to 113,000 kilograms from 65,000 kilograms, albeit it’ll take until April 2020 to complete expansion at its Moncton facility. With a keen focus on cannabis alternatives, such as oils, and its three-tiered growing system, which maximizes space efficiency while reducing costs, OrganiGram appears to be in great shape from a margin perspective.” The company has been working to boost their product lines due to the growing interest from the public in oils and cannabis related products. OrganiGram remains a company to look out for in the near future.

Another one of the lucrative ways to invest in the cannabis space has been through the ancillary companies that work within cannabis. Because of the new and changing legislation, many companies have had to conform their packaging to meet new restrictions. This has led to a boom of companies that produce just that. Companies such as Kush Bottles (KSHB) has been at the forefront of the packaging space for several years. The company recently reported a 173% year-over-year increase in sales which is quite substantial to look at when considering other similar markets.

Leafbuyer Technologies Inc. (LBUY) is another company that has been working in the ancillary market on cannabis for some time now. The company runs one of the primary sources for information in the cannabis space regarding news, dispensaries, products and more. Leafbuyer has also recently reported a massive increase in web traffic that helps to break down why so many investors continue to look at LBUY with a large amount of opportunity for the future. Companies like Leafbuyer are helping to bring the cannabis space together for the coming years, and for this reason, should not be overlooked.

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 NOW EXTENDED TO 10/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 ( CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

Perennial (DCM) and Aphria (APHQF) Sign LOI to Establish Joint Venture

Perennial and Aphria Sign LOI to Establish Joint Venture to Develop New, Consumer-Centric, Cannabis-Infused Products and Brands for the Canadian Market

Perennial Inc. (“Perennial”), a subsidiary of DATA Communications Management Corp. (DCM.TO) (“DCM”), and Aphria Inc. (TSX:APH and US OTC:APHQF) (“Aphria”) are pleased to announce they have signed a Letter of Intent to form a joint venture (the “JV”) to collaborate on the development of new products, brands and product categories that will drive the evolution of the Canadian adult-use cannabis market. It is expected that a definitive agreement formalizing the joint venture will be finalized within the coming weeks.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180814005226/en/

The JV will be powered by Aphria’s best-in-class cannabis production and Perennial’s industry-leading expertise in strategic brand development. The two companies share a cultural commitment to relentless innovation. This proposed collaboration will focus on developing industry-leading product innovations and brands that cater to the needs and wants of targeted adult-use consumer segments. As the cannabis industry expands into new and highly-anticipated product categories, Perennial and Aphria believe that a committed, consumer-centric approach will enable the JV to remain on the leading edge of the cannabis industry.

“Winning brands are built from the ground up, and we are excited by the opportunity to join forces with Aphria,” said Chris Lund, Chief Innovation Officer of Perennial. “Aphria shares Perennial’s vision of creating research-based, consumer-centric brands that are right for the Canadian marketplace.”

Continue reading
  7 Hits
  0 Comments
7 Hits
0 Comments

Canada: Grocery store locations among first round of approvals for Calgary cannabis dispensaries - Cannabis News

Calgarians are getting a better idea of where they’ll be able to purchase recreational marijuana, whether at a dedicated dispensary or perhaps under the roof of a supermarket.

And based on the addresses released by the City of Calgary, it looks like you might just be able to pick up cannabis while out grocery shopping at major grocery stores around the city.

Eleven Calgary Co-op locations, including one gas station, received approvals to sell cannabis.

Seven Real Canadian Superstores and one Real Canadian Liquor Store also got approval.

Click here to read the complete article

Continue reading
  11 Hits
  0 Comments
11 Hits
0 Comments

 Pure Global Cannabis, Inc (PRCNF) Uniquely Positioned to Lead Cannabis Health & Wellness Market– CFN Media

Pure Global Cannabis, Inc. Uniquely Positioned to Lead Cannabis Health & Wellness Market– CFN Media

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Pure Global Cannabis, Inc (PURE.V) (PRCNF) and its wholly-owned subsidiary, PureSinse Inc, taking the reins  with aspirations of becoming the leader in the cannabis health & wellness industry on both the Canadian and the international fronts.

The health and wellness industry, in general, has experienced growing interest in the past few years.   Baby boomers, who make up 70% of wellness industry consumers, are seeking alternatives to help improve their quality of life and prevent conditions related to aging. Additionally, members of Generation Z (the under 20-year-olds), are driving demand for alternative and more natural ways of achieving and maintaining wellness without using industrialized pharmaceuticals. Techniques that involve mindfulness, meditation, yoga, and general fitness are gaining popularity and consumers across both generations are now looking to add cannabis products to their health and wellness arsenal.

In the 12 years since medical cannabis has been legal in Canada, it has become increasingly clear cannabis is one of the most powerful medicinal plants known to man – not as only a treatment, but also as a preventative. With over 22,000 scientific studies on the medical use of cannabis, over 100 phytocannabinoid compounds have been discovered and more are uncovered each year. Each of these cannabinoids acts uniquely through CB1 and CB2 receptors, which make up the Endocannabinoid system. The Endocannabinoid system is comprised of a series of receptors in the human brain and body that respond pharmacologically to cannabis and have been discovered to play a crucial role in regulating our physiology. There has also been subsequent identification of endogenous cannabinoid compounds in the mammalian brain and body that bind to these receptors and this has significantly advanced the scientific understanding of human biology, health, and disease.

There is mounting evidence, for example, that those who use cannabis prior to working out can reduce anxiety, increase their pain threshold (more reps) and get into an aerobic zone. Those who use cannabis after their workout may find that it can help reduce inflammation, relieve pain, increase mass, and help them sleep better. To capture the attention of these pivotal markets, the family of products currently being developed by PureSinse are specially formulated to supplement lifestyles for better fitness, health, and wellbeing.

Health and Wellness Cannabis Products

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

Namaste Technologies Inc. (NXTTF) Announces Health Canada Final Inspection, Appointment of New COO David Giardino

Namaste Announces Health Canada Final Inspection, Appointment of New COO David Giardino and Filing of NCIB Shares

Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N.V) (M5BQ.F) (NXTTF) is pleased to announce that the Company’s wholly-owned subsidiary, Cannmart Inc. (“Cannmart”), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”), has completed Health Canada’s Pre-Sales License Inspection at the Cannmart facility in Etobicoke, Ontario . On July 31 st, 2018, Health Canada inspectors were on-site to verify information submitted by Cannmart as part of its application and in assessing compliance with the applicable sections of the ACMPR prior to license approval. The Pre-Sales License Inspection is one of the last steps prior to the issuance of a Sales License under the ACMPR.

Cannmart’s ACMPR “sales-only” license will be the first of its kind in Canada . The license enables Namaste to aggregate cannabis strains from licensed producers across the country, with the goal of offering medical patients access to the largest variety of medical cannabis products in a single platform. Namaste has positioned itself as a leader in the development of innovative cannabis e-commerce technology and will leverage its expertise and its platform powered by the Company’s wholly-owned subsidiary and AI technology company, Findify AB (“Findify” or “Findify.io”) to offer medical patients the most personalized user experience possible.

In anticipation of its upcoming ACMPR Sales License, Namaste is focused on accelerating patient acquisition through the launch of its updated version of the NamasteMD mobile app and by initiating several strategic marketing initiatives. NamasteMD is a telemedicine application which allows patients across Canada to access nurse practitioners or doctors for medical consultations via phone or video conference, free of charge from the comfort of their homes. NamasteMD is available in the App store for Apple devices, on the Google Play Store for Android devices and on the web at NamasteMD.com.

Namaste is also pleased to announce that pursuant to the Company’s July 16 th news release and the approval of a Normal Course Issuer Bid (“NCIB”) by the Toronto Venture Exchange (“TSXV”), the Company purchased a total of 1,111,700 common shares through the facilities of the TSXV in the month of July. The average price paid for each common share was $1.357 . The Company intends to continue the acquisition of its common shares subject to the terms of the NCIB. Details of the related transactions have been filed and are available on SEDAR.com

The Company is also pleased to announce the appointment of Mr. David Giardino as Chief Operating Officer (“COO”). David Giardino has extensive experience in managing enterprise-level operations and logistics, and will oversee all operations for Namaste’s domestic and international entities and in the execution of Namaste’s business strategy.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Novus Acquisition and Development, Corp. (NDEV) Reports Record Revenue for the Second Quarter 2018

Novus Reports Record Revenue for the Second Quarter 2018

Novus Acquisition and Development, Corp. (OTC PINK: NDEV), through its wholly owned subsidiary WCIG Insurance Services, Inc., is a diversified insurance entity in health, liability, annuity and accident, and, the nation’s first carrier/aggregator offering a cannabis health plan, today reported financial and operational results for its second quarter ended June 30, 2018.

Second Quarter 2018 Highlights:

Revenue increased 39% to $43,360 for the three months ended June 30, 2018, as compared to the three months ended June 30, 20178 consecutive quarters of revenue growthCommenced collaboration with EnlightenDemonstrated 60% profit margin (EBITDA) pricing structure in business modelNet income increased 126% to $25,860 for the three months ended June 30, 2018, as compared to the three months ended June 30, 2017Shareholder equity remained strong at $1,415,968 at June 30, 2018, decreasing slightly from $1,422,777 at March 31, 2018Cash and Cash Equivalents increased to $109,678 at June 30, 2018, from $106,271 at March 31, 2018

8th Consecutive Quarters of Sequential Increase in Revenue:

View photos

Novus’ Chief Executive Officer, Frank Labrozzi, commented, “As legalized medical cannabis continues to expand state by state, our goal for 2018 was to increase the visibility and awareness and ramp the covered lives of Novus Cannabis MedPlan. I am proud to report our 8th consecutive quarter of revenue growth and we are in great position to accelerate our market penetration and growth in the second half of 2018. Our confidence is due to our recently signed collaboration with Enlighten and having successfully added 13 dispensaries, cultivators and manufacturers that offer anywhere from 30% to 50% on cannabis medications to the Novus Cannabis MedPlan patient member base. Additionally, we are optimistic that many of the open discussions with potential strategic partners, medical cannabis businesses and dispensaries will result in signed agreements and roll-out over the remainder of 2018 and deliver further growth for 2019. Medical cannabis regulation continues to gain populous support due to its medical health benefits and is now approved and regulated in 30 U.S. states. We look to continue to be at the forefront of adding value to both medical cannabis consumers and businesses in an underserved and inefficient market.”

During the second quarter of 2018, Novus commenced business collaboration with Enlighten, a multifaceted cannabis technology company. Novus will utilize Enlighten’s interactive television technologies in a revenue sharing deal. Enlighten will place Novus’ message at the point of sales in 650 dispensaries across the country with advertising to engage and educate consumers on the Novus Cannabis MedPlan. When consumers are engaged Novus will get analytics of verified impressions from the consumer mobile devices for retargeting.

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

Aurora Cannabis Inc. (ACBFF) Company Ships Mother Plants to Denmark to Populate Aurora Nordic Phase I

Aurora Cannabis International Operational Update: Company Ships Mother Plants to Denmark to Populate Aurora Nordic Phase I

Aurora Cannabis Inc. (“Aurora” or the “Company”) (ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) is pleased to provide the following update on its international operations.

EUROPE

Denmark

The Company has successfully shipped cultivars from its Mountain facility to Denmark to commence populating the Phase I Aurora Nordic facility, a 100,000 square foot, retrofitted hybrid greenhouse, which will be ramping up to full production capacity of 8,000 kg per year of medical cannabis over the coming months. Aurora Nordic is a 51%-Aurora owned subsidiary owned in partnership with Alfred Pederson & Son. Both the Phase I facility and Phase II, a 1,000,000 square foot, hybrid greenhouse facility with a cultivation capacity of more than 120,000 KG per year, have been designed by Aurora Larssen Projects Ltd. (“ALPS”), and will be completed to EU GMP standards, incorporating leading edge technologies.

EU GMP

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Marijuana Stocks Newsletter – Monday August 13, 2018

What’s Next For GT Biopharma (GTBP)?During the period January 2018 – the present we have been watching the price, news and corporate developments at (GTBP).The company has added an ALL-STAR management roster, increased the strength of its board and received positive results on clinical trials. GT Biopharma (GTBP) has also begun to align itself with a “Major Pharma” company & that could present even more potential ahead.Click Here For More

Beleave, Inc. (BLEVF) Readying For Canada’s Next MoveA financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company Has Put Its Wheels In Motion & That Could Mean Big Potential AheadClick Here For More Information

Aspects of the Cannabis Market That Some Investors MissThe cannabis industry has been around for several years now, but it still remains an industry that is very much in its infant stages. As we move across the course of the next few years, it seems as though there are more principles to investing in this industry than ever before. More Details Here

Disclaimer: An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by GT Biopharma Inc. for a period beginning July 16, 2018 and ending August 16, 2018 to publicly disseminate information about (GTBP). We own zero shares. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018 NOW EXTENDED TO 8/31/2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

The post Marijuana Stocks Newsletter – Monday August 13, 2018 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
  7 Hits
  0 Comments
7 Hits
0 Comments

Maricann Group Inc. (MRRCF) Launches First Cannabidiol (CBD) Formulation Utilizing Patented Drug Delivery Technology in Germany

Maricann Launches First Cannabidiol (CBD) Formulation Utilizing Patented Drug Delivery Technology in Germany

Maricann Group Inc. (CSE:MARI)(75M.F)(MRRCF)(“Maricann” or the “Company) is excited to announce the official launch of MariPlant, the Company’s European nutraceutical line of business. MariPlant products will be available for sale in Germany through www.mariplant.de beginning on August 20, 2018, with strategic expansion planned throughout the European Union.  Maricann’s first product launch is a soft gel formulation loaded with 25mg of CBD that utilizes the multi-patented VESIsorb® delivery system to ensure optimum absorption and bioavailability.

“Maricann is pleased to bring a superior CBD product to the German marketplace. This development symbolizes a significant move to strengthen our global leadership position as we introduce the first of many patented formulations that utilize VESIsorb,” Stated Ben Ward, CEO.

Maricann’s product launch represents many first-to-market milestones in the German cannabis industry, including the first:

VESIsorb® formulation specifically adapted for cannabinoids;Standardized CBD product with measured and proven stability data; andFormulation with a strategic CBD:BCP (beta-caryophyllene) ratio of 4:1

In 2017, through a commercialization agreement with SourceOne Global Partners, Maricann acquired the supply rights to VESIsorb® for use with cannabis for human consumption in Canada, Germany, and other territories.

Multiple clinical studies have demonstrated the absorption and bioavailability benefits of VESIsorb®, a science-backed drug delivery technology with a robust portfolio of international patents. VESIsorb® has now been successfully adapted to optimize the performance of cannabis formulations in the human body. Since 2007, close to 200 million consumers in all six continents have safely and effectively used a natural product formulated with VESIsorb®.

Continue reading
  7 Hits
  0 Comments
7 Hits
0 Comments

The Biggest Cannabis Gainers During The Summer of 2018

The cannabis market has been growing with a massive amount of propensity toward the future, but many stocks have grown out of this and have moved to the forefront of the industry in recent times. Although there are still the legislative challenges to deal with, it seems as though the next few years will be extremely instrumental in developing the cannabis market as a whole.

The company Cronos Group Inc. (NASDAQ: CRON) has been at the forefront of the industry for some time now. Cronos notably became the first cannabis company to list on a U.S. exchange as popular as the NASDAQ and for that reason, has received a large amount of notoriety. The company recently “rose 5.72% on higher than average trading volume on the Nasdaq, closing the day at $6.10 USD per share. Today, Cronos Group announced that it has entered into a supply agreement with one of the largest cannabis companies in the world by revenue in the first quarter of 2018, Cura Select Canada, Ltd.” Supply agreements and various partnerships throughout the industry have proven to be one of the fastest ways that the market has continued to grow, and for this reason, the Cronos Group remains one of the very interesting stock choices to look out for.

The next stock on the list is the company CV Sciences (OTC:CVSI). According to one report “Shares of CV Sciences, Inc. rose 12.53% on higher than average trading volume on the OTC markets, closing the day at $4.22 USD per share. Yesterday, CV Sciences announced the appointment of Joseph Maroon, MD, FACS, to its Board of Directors.” CV has also managed to stay one of the larger players in the industry as the market continues to grow.

Next on the list is the company MedMen Enterprises (OTC:MMNFF). MedMen is a Californian company that has worked to become essentially the “7/11” of weed. The company has opened dispensaries in various places around the state and has promoted their substance as some of the highest quality cannabis in a mass produced way. One report shows that “Shares of MedMen Enterprises Inc. rose 7.06% today on higher than average trading volume on the OTC markets, closing the day at $3.0559 USD per share. Yesterday, MedMen announced that its subordinate voting shares are now listed on the Frankfurt Stock Exchange and are trading under the symbol “A2JM6N.”

The last stock on the list is the company Marapharm Ventures ( MRPHF ). Marapharm has also been at the forefront of the cannabis market for several years now, and has seen their stock increase quite substantially. The company states that they are “a public company which invests in health and wellness, including medical and recreational marijuana.” With massive plans for future growth and a large amount of exposure to the cannabis market, it seems as though Marapharm is only poised to continue this growth trend into the future.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Marijuana Stocks With Uptrend Potential In the Near Future

The cannabis market has remained one of the industries with the most amount of potential for the coming years. With many stocks entering the market promising new innovations to the industry, it seems as though the next few years will be incremental for growth in the sector. Several stocks in the space have managed to remain extremely lucrative given the amount of compositors entering the industry, and here are just a few.

The company Solis Tek Inc. (OTC:SLTK) recently reported large numbers in terms of stock growth. According to one report “Shares of Solis Tek Inc. rose 6.73% on lower than the average trading volume on the OTC markets, closing the day at $0.555 USD per share. Recently, Solis Tek provided an update for its cannabis cultivation and processing facility in Arizona.” Many stocks in the industry have benefitted from the large and growing demand for cannabis in the space, and as the recreational industry continues to grow, so do stocks that help to meet this demand. Solis Tek remains one of the stocks to watch over the course of the next few years and beyond.

The next company on the list is the company Auxly Cannabis Group (OTC:CBWFF). Auxly has been working to become one of the primary Dealer’s of cannabis in the market, and recently obtained a Dealer’s License through their wholly-owned subsidiary known as Dosecann Inc. Because of this, “Shares of Auxly Cannabis Group Inc. rose 8.81% on lower than average trading volume on the OTC markets, closing the day at $0.642 USD per share.” Although much of the growth in the industry seems to come from speculation, this is very much due to the infancy of the market as a whole. As cannabis continues to mature in its entirety, investors will begin to start investing on intrinsic value rather than simply news that comes out pertaining to a stock.

The company Leafbuyer Technologies Inc. (OTC:( LBUY ) been at the forefront of the industry for some time now as one of the go-to spots to find everything from news about cannabis, to where to find the actual plant near the consumer. Because of this, Leafbuyer has become one of the primary sources for news in the space overall. The company has reported massive amounts of growth in terms of web traffic over the past year or so, with only more good news to come. As one of the bigger players in the web market of cannabis, Leafbuyer remains an interesting stock to watch over the course of the near future.

Many of the companies in the cannabis space have been benefitting off of being in the ancillary market of cannabis rather than in the pure-play cannabis space. Because of this, investors have been turning to other options in the industry to have a diverse portfolio with varying degrees of involvement in the actual cannabis market. Cannabis as a whole however is still very much in its infant stages which means that there is a large amount of room to grow as we move toward the near future. Only time will tell how the combination of positive legislation in the space and the changing public sentiment will combine to help the market reach its full potential.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

GW Pharmaceuticals (GWPH) Updates on Fiscal Q3 Results & Epidiolex Progress

GW Pharma Updates on Fiscal Q3 Results & Epidiolex ProgressGW Pharmaceuticals (NASDAQ: GWPH), a British biopharma, recently reported its third-quarter earnings and progress on its cannabis-based drug for people suffering from epilepsy. The biopharma company reported an EPS of -$1.26 in fiscal Q3 compared with the Thomson Reuters’ estimate of -$2.40, while its top line touched $3.46 million in the quarter compared with Reuters’ estimates of $2 million. Apart from the financials, the highlight of the call was the update on its flagship cannabis-based epilepsy drug Epidiolex, which received U.S. FDA approval in June and will most likely hit the markets this fall.

The post GW Pharmaceuticals (GWPH) Updates on Fiscal Q3 Results & Epidiolex Progress appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
  6 Hits
  0 Comments
6 Hits
0 Comments

A Millennial Couple Finds Their Sweet Spot In Cannabis Soda - Cannabis News

"It’s an edible but it hits you less a time versus an edible where it takes longer to work. And there’s no learning curve - everyone knows how to drink a beverage.”

It was never meant to be taken seriously. When Amy Ludlum, 32, and Peter Bishop, 29, co-founders of the San Francisco-based cannabis soda brand California Dreamin’, first came up with the idea for what would later become their business, they just wanted to have fun.

The millennial couple was on a camping trip with friends and they wanted to create a healthier alternative to drinking beer and being hung over. To their surprise, the homemade concoction turned out to be a big hit.

Click here to read the complete article

Iris Dorbian ~ Forbes.com ~ 

Continue reading
  14 Hits
  0 Comments
14 Hits
0 Comments

Marijuana Stocks Newsletter – Happy Friday – August 10, 2018

Humble Beginnings Could Lead To Big OpportunityDuring the period January 2018 – the present we have been watching the price, news and corporate developments at (GTBP).The company has added an ALL-STAR management roster, increased the strength of its board and received positive results on clinical trials. GT Biopharma (GTBP) has also begun to align itself with a “Major Pharma” company & that could present even more potential ahead.Click Here For More

Canada’s Craft MJ Market Presents New PotentialA financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company Has Put Its Wheels In Motion & That Could Mean Big Potential AheadClick Here For More Information

Aspects of the Cannabis Market That Some Investors MissThe cannabis industry has been around for several years now, but it still remains an industry that is very much in its infant stages. As we move across the course of the next few years, it seems as though there are more principles to investing in this industry than ever before. More Details Here

This email is for ‘%%emailaddress%%’ You have received this email because you are subscribed to MarijuanaStocks.com | Disclaimer: An affiliate of MarijuanaStocks.com – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by GT Biopharma Inc. for a period beginning July 16, 2018 and ending August 16, 2018 to publicly disseminate information about (GTBP). We own zero shares. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

The post Marijuana Stocks Newsletter – Happy Friday – August 10, 2018 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
  19 Hits
  0 Comments
19 Hits
0 Comments

Future Farm Technologies Inc. (FFRMF) Announces Strategic Financing, Project Development in Puerto Rico

Future Farm Announces Strategic Financing, Project Development in Puerto Rico and New Corporate Secretary

Future Farm Technologies Inc. (the “Company” or “Future Farm”) (FFT.CN) (FFRMF) announces that it has closed on a new investment from a fund of Yorkville Advisors Global, LP (“Yorkville”). Proceeds from the private placement will be used to refinance a previous investment made by Yorkville and to support the continued development of the Company’s various projects throughout North America.

“Yorkville has proven to be a very supportive partner for our endeavors,” comments William Gildea, CEO of Future Farm. “We are both committed to see our investments succeed and to expand the value of our portfolio for shareholders.”

In addition to the financing, the Company is pleased to provide an update on operations in Puerto Rico. Three of Future Farm’s senior advisers will be onsite next week in Puerto Rico to oversee the development of FFPR, LLC (“FFPR”), which is set up to own and operate five medical dispensaries on the island. Led by Tom Barrette and George Groccia, the team will work with its partners, including Clinica Verde, to design and implement collaborative, operational management processes. Clinica Verde operates four existing Registered Marijuana Dispensaries in Puerto Rico.

Future Farm’s finance team will also be onsite to help develop and implement a seamless data analytics process and map out real-time reporting that will be integrated throughout all locations. In addition to data mapping, the team will also focus on selecting the remaining three RMD locations. Once fully established, FFPR’s dispensaries will help ensure that the over twenty-thousand registered medical marijuana patients have access to the highest quality care the island has to offer.

Continue reading
  12 Hits
  0 Comments
12 Hits
0 Comments

The Growing Cannabis Market Across Florida and Beyond

The cannabis market throughout North America has been hailed as one of the fastest growing markets for some time now, but new updates to legislation continue to change the way that we interact with the industry. For this reason, many individuals have been moving their eyes toward the marijuana market as more and more reasons continue to fuel opportunity in the space.

One of the markets that many people have been talking about, and one that has still remained under the radar is that of the industry in Florida. Much of the news usually concerns the state of California, but other states in the U.S. are also showing great amounts of promise. The state has been steadily able to approve as many as 2,580 patients for medicinal use per week, which means that they have already seen an increase of as much as 100% since the beginning of this year alone. This is a massive number considering the time it has taken other states to reach a similar amount of patients. Florida has also been known to be one of the more restrictive states with edible products as well as flower, not being available for purchase at this point yet. According to one report “In 2014, medical marijuana was approved but with only five licenses to be awarded. In 2016, voters approved a constitutional amendment that expanded the medical marijuana program. In order to institute the expansion, health officials were ordered to issue 10 new licenses. This included applicants who had legal challenges pending as of January 2017.” These new licenses have continued to help build the industry to places that no one thought it could reach.

According to Tyler Beuerlein, from cannabis payment company Hypur Inc. “the Florida market has issues 13 licenses. The license gives the company the ability to have their own cultivation property and 25 dispensaries. The value is substantial and some are going for as much as $50 million. It is very appealing from an investment perspective.” Many investors have shared this opinion, as Florida continues to work on growing out its marijuana sector.

Matthew Ginder, a partner at Greenspoon Marder, a local law firm that works within the cannabis industry, stated that “There are other companies that have followed suit and are here now but may not have dispensaries open yet, such as AltMed, MedMen, IAnthus (ITHUF) , Liberty Health Sciences (LHSIF) and a few others,” Ginder said. “Competition is expected to increase as the state issues additional licenses as patient count rises and multistate operators enter through acquisitions of existing licensed MMTCs (medical marijuana treatment centers).” The increase in competition will likely help the market to reach somewhere near its full potential in the near future as more and more companies begin to develop new strategies to entering the market. He continued to state that the population “and the amount of tourists that visit the state, an estimated 100 million annually, a fully implemented recreational program could generate a few billion dollars in revenue.” This would massively help the state to work on various projects given this influx of potential capital.

The only issue that currently remains is that of the legislation behind the product. If the state is able to make the legislation more acceptable to what the people would like to see given the positive sentiment behind cannabis, the market will likely be able to flourish as we move toward the near future. The hopes are high that over the course of the next few years. The industry will be able to make its mark across the cannabis sector.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments